Trial intelligence / Profile preview

Intravenous R744 in chronic renal failure patients with renal anemia

jRCT2080220220Phase 2

Sponsor
Chugai Pharmaceutical Co., Ltd.
Start
Mar 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of Carbon dioxide in anemia of renal disease and chronic kidney disease (CKD), sponsored by Chugai Pharmaceutical Co., Ltd.

02

Drugs

Carbon dioxide
03

Conditions

anemia of renal diseasechronic kidney disease (CKD)

Beyond the preview

Go deeper on jRCT2080220220.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080220220.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call